Based on the existing varieties, brands, channels and marketing advantages, Jointown conducts targeted development of self-operated industrial and OEM products by virtue of big data accumulated by the Company's "hundred-billion-level" supply chain service platform, and then distributes pharmaceuticals to terminal or C-end consumers through its full-channel sales network.

In terms of pharmaceutical production, Jingfeng Pharmaceutical currently holds over 200 approved drug registration numbers, covering 186 preparations and 27 active pharmaceutical ingredients across therapeutic areas including systemic anti-infectives, digestive system and metabolism, dermatology, neurology, cardiovascular and cerebrovascular diseases, and respiratory diseases. In terms of pharmaceutical R&D, Jingfeng Pharmaceutical focuses on four major product series, namely hypoglycemic, topical, cardiovascular and cerebrovascular, and anti-infective products. To date, 15 drug varieties have passed consistency evaluation, while the pipeline under development includes 25 preparations and 11 active pharmaceutical ingredients, featuring flagship products such as the "Metformin" series and Compound Clotrimazole Cream. In addition, Jingfeng Pharmaceutical is making every effort to develop two comprehensive patient-centered solutions covering both intra-hospital and out-of-hospital settings: a "Full Disease Course Solution for Type II Diabetes Patients with Comorbid Hypertension/Hyperlipidemia" and a "Jingfeng Topical Medication Combined Therapy: A Comprehensive Solution for Chronic Skin Conditions". Looking ahead, Jingfeng Pharmaceutical will leverage these two solutions to develop a dual-track chronic disease management model covering Type II diabetes and topical medications, thereby providing chronic disease patients with a comprehensive healthcare service system.

Jiuxin TCM Group Co., Ltd., a subsidiary of the Company, focused on developing Daodi Herb and Chinese herbal pieces businesses. The Company operates five major brands, namely "Jiuxin", "JoinNative", "Jingui Dejitang", "Jiu Xin Tang", and "Zhenyang", along with six major product series encompassing standard decoction pieces, refined decoction pieces, directly consumable decoction pieces, toxic decoction pieces, ginseng and deer antler delicacies, and medicinal food homologous products, thereby meeting the diverse needs of the market.

The medical devices industrial and OEM business covers R&D and registration, clinical services, product marketing, and production management. The Company has registered two proprietary brands, Metiko and Flo's, obtained 19 MAH Class II product registration certificates and 28 Class I product filing certificates, and holds 225 OEM medical device product specifications. Through independent R&D and the production of its own brand and OEM products, the Company has developed products with independent intellectual property rights and exclusive sales rights, thereby enhancing product competitiveness. At the same time, the Company continuously explores external sales channels to expand market coverage, steadily increasing market share and promoting sustained development in the medical device industry and OEM business sectors.